C17H12N2O2
Neat
276.30
330792-69-3; 2-[(Methoxy)(4-phenoxyphenyl)methylene]malononitrile; 2-((Methoxy)(4-phenoxyphenyl)methylene)malononitrile; RefChem:249509; 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile; Propanedinitrile, 2-[methoxy(4-phenoxyphenyl)methylene]-; Propanedinitrile, [methoxy(4-phenoxyphenyl)methylene]-; MFCD20140315; 2-[methoxy-(4-phenoxyphenyl)methylidene]propanedinitrile; 2-[methoxy(4-phenoxyphenyl)methylene]Propanedinitrile; 1 and 1-Dicyano-2-methoxy-2-(4-phenoxyphenyl)ethene; 2-[Methoxy(4-phenoxyphenyl)methylene]malononitrile; Ibrutinib Impurity 162; SCHEMBL200799; RS2X48F2U5; Zanubrutinib Related Compound 3; IRVRZQLHMPWLLY-UHFFFAOYSA-N; DTXSID901220892; CS-M2595; ZB1493
2-[methoxy-(4-phenoxyphenyl)methylidene]propanedinitrile
InChI=1S/C17H12N2O2/c1-20-17(14(11-18)12-19)13-7-9-16(10-8-13)21-15-5-3-2-4-6-15/h2-10H,1H3